Search Medical Condition
Please enter condition
Please choose location

Anxiety Disorders Clinical Trials

A listing of Anxiety Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (343) clinical trials

Worry too much? Nervous or irritable? On edge? Tense in the neck and shoulders? Fearful? Is it hard to fall or stay asleep? If you are experiencing any of the above symptoms, you may be suffering from anxiety and could benefit from a medication research study. Pacific Clinical Research Medical ...

Phase N/A

A clinical study designed to collect information on the safety and efficacy of an anti-depressant to treat depression, OCD, or anxiety with or without CBT therapy.

Phase

The purpose of this research study is to investigate brain changes in adolescents who are currently experiencing depressive and/or anxiety symptoms and have a family history of bipolar disorder. Participants will be randomized to escitalopram and psychotherapy or placebo and psychotherapy for 16-week treatment.

Phase N/A

We are doing a treatment study to examine the use of transcranial magnetic stimulation (TMS) in treating people with OCD and to investigate what areas of the brain are involved during emotional learning. TMS is a noninvasive method in which a magnetic “coil” is placed near an individual’s head and ...

Phase N/A

Effects of a Probiotic Supplement on Symptoms of Attention Deficit Hyperactivity Disorder and Anxiety in Children

Participants will be recruited using information distributed through schools in the Annapolis Valley area and with the use of advertising campaigns visible across Nova Scotia as previously described. Interested participants will be directed to the study's website (www.probioticstudy.com), where they will be able to view a complete summary of the ...

Phase

Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans

The study will use a double-blind, cross-over design in which each subject will receive placebo and SRX246 for 5-7 days before testing (given in counter-balanced order). The study will examine the effect of the drug on the potentiation of startle using a well-established paradigm that involves anticipation of no-shock, predictable ...

Phase

Descriptive Study of a Phytotherapy Strategy for Sleep Disorders Related to Anxiety With Phytostandard Eschscholtzia and Valerian a Dietary Supplement Based on Eschscholtzia and Valerian Extracts

For this study, 40 patients are going to be included. They will have a supplementation of Phytostandard Eschscholtzia and valerian, from 2 to 4 tablets per day during 28 days. on the one hand, during the two visits (inclusion and follow-up), the investigator completes the Hamilton Anxiety Scale (HAM-A). During ...

Phase N/A

The Use of a FDA Cleared Drug-free Breathing System for Anxiety and Panic Disorders in Children and Teens

The Freespira Breathing System (FBS; www.freespira.com) developed by Palo Alto Health Sciences, Inc, is a portable home device , and has been employed in breathing biofeedback in adults with panic disorder (PD). The FBS has now received FDA clearance for the treatment of PD adults and is currently commercially available ...

Phase N/A

A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder

This is a Phase 2a randomized (study drug assigned by chance), double-blind (neither the Investigator nor the participants know about the study intervention), placebo-controlled, parallel-group, multi-center study of JNJ-42165279 in participants with social anxiety disorder. Participants will receive 25 milligram (mg) JNJ-42165279 or matching placebo orally once-daily from Day 1 ...

Phase

Pegasys VR: Integrating Virtual Humans in the Treatment of Child Social Anxiety

Anxiety disorders are the most common psychiatric disorders among youth, with lifetime prevalence ranging between 18-20% of the general population. Among anxiety disorders, social anxiety disorder (SAD) affects 8% of all youth, resulting in significant short and long-term impairment, including increased likelihood of substance abuse, limited academic achievement, attenuated occupational ...

Phase